Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype.
EMT
Sirtuins
cancer
cancer therapy
epigenetics
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
07
2018
accepted:
14
01
2019
entrez:
15
2
2019
pubmed:
15
2
2019
medline:
15
2
2019
Statut:
epublish
Résumé
Sirtuins (SIRTs), class III histone deacetylases, are differentially expressed in several human cancers, where they display both oncogenic and tumor-suppressive properties depending on cellular context and experimental conditions. SIRTs are involved in many important biological processes and play a critical role in cancer initiation, promotion, and progression. A growing body of evidence indicates the involvement of SIRTs in regulating three important tumor processes: epithelial-to-mesenchymal transition (EMT), invasion, and metastasis. Many SIRTs are responsible for cellular metabolic reprogramming and drug resistance by inactivating cell death pathways and promoting uncontrolled proliferation. In this review, we summarize current knowledge on the role of SIRTs in cancer and discuss their puzzling dual function as tumor suppressors and tumor promoters, important for the future development of novel tailored SIRT-based cancer therapies.
Identifiants
pubmed: 30761005
doi: 10.3389/fphar.2019.00038
pmc: PMC6363704
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
38Références
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
J Surg Res. 2000 Jun 15;91(2):130-4
pubmed: 10839961
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8658-63
pubmed: 10890892
J Biol Chem. 2001 Oct 19;276(42):38837-43
pubmed: 11483616
J Pharmacol Exp Ther. 2001 Nov;299(2):426-33
pubmed: 11602651
Cell. 2001 Oct 19;107(2):149-59
pubmed: 11672523
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15113-8
pubmed: 11752457
Biochem Biophys Res Commun. 2002 Mar 8;291(4):1001-5
pubmed: 11866465
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13653-8
pubmed: 12374852
Nature. 2003 Sep 11;425(6954):191-6
pubmed: 12939617
Anticancer Res. 2004 Sep-Oct;24(5A):2783-840
pubmed: 15517885
Mol Biol Cell. 2005 Oct;16(10):4623-35
pubmed: 16079181
Mol Cell Biol. 2005 Sep;25(18):8108-25
pubmed: 16135802
Oncogene. 2006 Jan 12;25(2):176-85
pubmed: 16170353
J Med Chem. 2005 Dec 15;48(25):8045-54
pubmed: 16335928
Cancer Res. 2006 Apr 15;66(8):4368-77
pubmed: 16618762
Genes Dev. 2006 May 1;20(9):1075-80
pubmed: 16618798
Nat Rev Drug Discov. 2006 Jun;5(6):493-506
pubmed: 16732220
Oncogene. 2007 Feb 15;26(7):945-57
pubmed: 16909107
Cell. 2006 Sep 8;126(5):941-54
pubmed: 16959573
Cell Cycle. 2007 May 2;6(9):1011-8
pubmed: 17457050
Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52
pubmed: 17548692
J Med Chem. 2008 Mar 13;51(5):1203-13
pubmed: 18269226
Nature. 2008 Mar 27;452(7186):492-6
pubmed: 18337721
PLoS One. 2008 Apr 16;3(4):e2020
pubmed: 18414679
Cancer Cell. 2008 May;13(5):454-63
pubmed: 18455128
Biochem Biophys Res Commun. 2008 Aug 29;373(3):423-8
pubmed: 18573234
Ann Oncol. 2008 Nov;19(11):1903-9
pubmed: 18632723
Am J Surg Pathol. 2008 Oct;32(10):1523-31
pubmed: 18724249
Oncogene. 2009 Feb 12;28(6):781-91
pubmed: 19060927
J Biol Chem. 2009 Feb 6;284(6):3823-32
pubmed: 19075016
J Cell Biochem. 2009 Mar 1;106(4):643-50
pubmed: 19160423
Int J Biol Sci. 2009;5(2):147-52
pubmed: 19173036
Nat Cell Biol. 2009 Apr;11(4):492-500
pubmed: 19295512
J Cell Biol. 2009 Apr 20;185(2):203-11
pubmed: 19364925
Int J Dev Biol. 2009;53(2-3):303-22
pubmed: 19378253
Oncogene. 2009 Aug 13;28(32):2882-93
pubmed: 19503100
Cell Cycle. 2009 Aug 15;8(16):2664-6
pubmed: 19625767
Biochim Biophys Acta. 2010 Aug;1804(8):1666-75
pubmed: 19879981
Biochim Biophys Acta. 2010 Aug;1804(8):1591-603
pubmed: 20132909
Mol Cancer Ther. 2010 Apr;9(4):844-55
pubmed: 20371709
PLoS One. 2010 May 05;5(5):e10486
pubmed: 20463968
Biochem Pharmacol. 2010 Dec 15;80(12):1771-92
pubmed: 20599773
Carcinogenesis. 2010 Oct;31(10):1726-33
pubmed: 20675343
J Med Chem. 2011 Jan 27;54(2):417-32
pubmed: 21080630
J Gynecol Oncol. 2010 Dec 30;21(4):262-8
pubmed: 21278889
Bioorg Med Chem. 2011 Jun 15;19(12):3669-77
pubmed: 21315612
J Biol Chem. 2011 Apr 22;286(16):14575-87
pubmed: 21362626
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Cell. 2011 Mar 8;19(3):416-28
pubmed: 21397863
Science. 2011 Jun 17;332(6036):1443-6
pubmed: 21680843
J Aging Res. 2011;2011:235754
pubmed: 21766030
Handb Exp Pharmacol. 2011;206:163-88
pubmed: 21879450
Genes Cancer. 2011 Jun;2(6):648-62
pubmed: 21941620
Br J Haematol. 2011 Dec;155(5):588-98
pubmed: 21950728
Cancer Cell. 2011 Oct 18;20(4):487-99
pubmed: 22014574
Int J Mol Sci. 2011;12(9):6226-39
pubmed: 22016654
Science. 2011 Nov 11;334(6057):806-9
pubmed: 22076378
Blood. 2012 Feb 23;119(8):1904-14
pubmed: 22207735
Oncology. 2011;81(5-6):325-9
pubmed: 22237050
Oncogene. 2012 Oct 25;31(43):4619-29
pubmed: 22249256
Front Pharmacol. 2012 Jan 31;3:4
pubmed: 22319497
Int J Cancer. 2012 Nov 1;131(9):2044-55
pubmed: 22322739
Oncol Rep. 2012 Jun;27(6):1726-32
pubmed: 22470132
Nature. 2012 Jul 5;487(7405):114-8
pubmed: 22722849
Trends Mol Med. 2012 Sep;18(9):516-23
pubmed: 22749020
Cancer Res. 2012 Oct 1;72(19):5130-40
pubmed: 22850421
Mol Cell Biol. 2012 Dec;32(24):5022-34
pubmed: 23045395
Hepatology. 2013 Mar;57(3):1055-67
pubmed: 23079745
Cell Death Differ. 2013 Mar;20(3):503-14
pubmed: 23175188
J Med Chem. 2012 Dec 27;55(24):10937-47
pubmed: 23189967
Br J Haematol. 2013 Mar;160(5):714-7
pubmed: 23205612
Curr Mol Med. 2013 Mar;13(3):387-400
pubmed: 23331011
Hepatology. 2013 Jun;57(6):2287-98
pubmed: 23348706
Tumour Biol. 2013 Jun;34(3):1847-54
pubmed: 23475622
Curr Opin Hematol. 2013 Jul;20(4):308-13
pubmed: 23519155
Nature. 2013 Apr 4;496(7443):110-3
pubmed: 23552949
Cancer Cell. 2013 Apr 15;23(4):450-63
pubmed: 23562301
Cell Rep. 2013 Apr 25;3(4):1175-86
pubmed: 23583181
J Phys Chem Lett. 2013 Feb 7;4(3):491-495
pubmed: 23585919
J Natl Cancer Inst. 2013 Jun 19;105(12):887-98
pubmed: 23704280
Mol Cancer Res. 2013 Sep;11(9):1072-7
pubmed: 23723075
BMC Cancer. 2013 Jun 14;13:290
pubmed: 23768087
Neoplasma. 2013;60(5):511-5
pubmed: 23790169
J Cell Sci. 2013 Sep 1;126(Pt 17):3939-47
pubmed: 23843607
Oncotarget. 2013 Jul;4(7):984-94
pubmed: 23846322
Cell Metab. 2013 Aug 6;18(2):145-6
pubmed: 23931748
Genes Cancer. 2013 Mar;4(3-4):97-104
pubmed: 24020000
J Biol Chem. 2013 Oct 25;288(43):31350-6
pubmed: 24052263
Eur J Cancer. 2014 Jan;50(2):290-301
pubmed: 24183459
Int J Clin Exp Pathol. 2013 Oct 15;6(11):2357-65
pubmed: 24228097
Biochem Biophys Res Commun. 2014 Jan 3;443(1):156-60
pubmed: 24287180
Mol Med Rep. 2014 Mar;9(3):882-8
pubmed: 24366394
J Biol Chem. 2014 Feb 14;289(7):4135-44
pubmed: 24368766
Trends Pharmacol Sci. 2014 Mar;35(3):146-54
pubmed: 24439680
Cancer Sci. 2014 Apr;105(4):445-54
pubmed: 24484175
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Cell Metab. 2014 Apr 1;19(4):605-17
pubmed: 24703693
Cancer Res. 2014 Jun 15;74(12):3228-37
pubmed: 24713434
Oncotarget. 2014 Apr 30;5(8):2085-95
pubmed: 24742694
Arch Biochem Biophys. 2014 Dec 1;563:94-100
pubmed: 24751483
Clin Cancer Res. 2014 Jul 1;20(13):3434-45
pubmed: 24771643
Mol Cancer Res. 2014 Sep;12(9):1244-53
pubmed: 24866770
Tumour Biol. 2014 Nov;35(11):10699-705
pubmed: 25070488
Dis Model Mech. 2014 Sep;7(9):1023-32
pubmed: 25085992
Biomed Res Int. 2014;2014:871263
pubmed: 25105144
Cancer Lett. 2014 Dec 28;355(2):184-91
pubmed: 25172416
Mol Cancer Ther. 2015 Jan;14(1):183-92
pubmed: 25411356
Mol Cancer. 2014 Nov 26;13:254
pubmed: 25424420
Am J Pathol. 2015 Jan;185(1):26-8
pubmed: 25452121
Exp Gerontol. 2015 Jan;61:130-41
pubmed: 25482473
BMC Cancer. 2014 Dec 18;14:978
pubmed: 25522783
Am J Pathol. 2015 Jan;185(1):266-79
pubmed: 25529796
Antioxid Redox Signal. 2015 Apr 20;22(12):1060-77
pubmed: 25545135
Cancer Metab. 2014 Nov 28;2:17
pubmed: 25671107
Eur J Pharmacol. 2015 Jun 15;757:59-67
pubmed: 25843411
Oncotarget. 2015 May 10;6(13):10868-79
pubmed: 25869101
PLoS One. 2015 Apr 27;10(4):e0124670
pubmed: 25915617
Asian Pac J Cancer Prev. 2015;16(8):3573-7
pubmed: 25921180
Breast Cancer (Auckl). 2015 Apr 09;9:3-8
pubmed: 25922576
Sci Rep. 2015 Apr 29;5:9841
pubmed: 25923013
Int J Clin Exp Pathol. 2015 Feb 01;8(2):1938-45
pubmed: 25973086
Cancer Cell Int. 2015 May 13;15:52
pubmed: 26052253
Br J Cancer. 2015 Jul 28;113(3):492-9
pubmed: 26086877
Sci China Life Sci. 2015 Sep;58(9):912-4
pubmed: 26208827
Semin Cell Dev Biol. 2015 Jul;43:33-42
pubmed: 26238985
Exp Biol Med (Maywood). 2016 Jan;241(2):140-6
pubmed: 26316584
J Allergy Clin Immunol. 2016 Jan;137(1):87-98.e7
pubmed: 26342525
Nat Rev Cancer. 2015 Oct;15(10):608-24
pubmed: 26383140
Mol Cells. 2015 Sep;38(9):750-8
pubmed: 26420294
Med Oncol. 2015 Dec;32(12):260
pubmed: 26520143
Nucleic Acids Res. 2016 May 5;44(8):3629-42
pubmed: 26704979
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Mol Cancer. 2016 Feb 24;15:18
pubmed: 26905733
Sci Rep. 2016 Mar 04;6:22622
pubmed: 26940009
Cancer Lett. 2016 Jun 1;375(2):274-283
pubmed: 26975631
Nat Struct Mol Biol. 2016 May;23(5):434-40
pubmed: 27043296
Cell. 2016 Jun 2;165(6):1401-1415
pubmed: 27180906
Clin Epigenetics. 2016 May 25;8:61
pubmed: 27226812
Oxid Med Cell Longev. 2016;2016:3031459
pubmed: 27379175
Nat Commun. 2016 Jul 20;7:12235
pubmed: 27436229
Oncotarget. 2016 Oct 25;7(43):70058-70065
pubmed: 27588402
Oncol Lett. 2016 Oct;12(4):2606-2612
pubmed: 27698834
Exp Hematol. 2017 Feb;46:62-69
pubmed: 27725192
Oncotarget. 2016 Jun 28;7(26):40377-40386
pubmed: 27777384
Oncotarget. 2017 Mar 21;8(12):18848-18860
pubmed: 28061480
Transcription. 2017 Mar 15;8(2):67-74
pubmed: 28067587
Nat Rev Nephrol. 2017 Apr;13(4):213-225
pubmed: 28163307
Cell Rep. 2017 Feb 21;18(8):1858-1868
pubmed: 28228253
Mol Med Rep. 2017 Apr;15(4):1638-1646
pubmed: 28259910
Int J Oncol. 2017 May;50(5):1683-1692
pubmed: 28393212
Elife. 2017 Apr 13;6:
pubmed: 28406396
Oncol Rep. 2017 Jul;38(1):368-376
pubmed: 28534958
Cancers (Basel). 2017 Jul 12;9(7):null
pubmed: 28704962
Nat Commun. 2017 Aug 22;8(1):318
pubmed: 28827661
Am J Cancer Res. 2017 Sep 01;7(9):1788-1803
pubmed: 28979804
Transl Oncol. 2017 Dec;10(6):917-927
pubmed: 28992545
Aging Cell. 2017 Dec;16(6):1208-1218
pubmed: 28994177
Oncotarget. 2017 Jun 15;8(39):66343-66351
pubmed: 29029516
Oncotarget. 2017 Aug 24;8(44):77309-77316
pubmed: 29100388
Genes Cancer. 2017 Sep;8(9-10):701-712
pubmed: 29234488
J Clin Oncol. 1989 Apr;7(4):499-508
pubmed: 2926472
Int J Mol Sci. 2017 Dec 28;19(1):null
pubmed: 29283424
Haematologica. 2018 Jan;103(1):1-4
pubmed: 29290628
Oncotarget. 2017 Dec 6;8(67):110922-110930
pubmed: 29340027
Cell Death Dis. 2018 Jan 26;9(2):136
pubmed: 29374154
Nat Commun. 2018 Feb 7;9(1):545
pubmed: 29416026
J Mol Histol. 2018 Jun;49(3):235-244
pubmed: 29468299
Clin Cancer Res. 2018 Jun 15;24(12):2886-2900
pubmed: 29535128
PLoS Genet. 2018 Jun 7;14(6):e1007362
pubmed: 29879107
J Cancer. 2018 Apr 30;9(11):2012-2023
pubmed: 29896286
Onco Targets Ther. 2018 Jun 11;11:3395-3400
pubmed: 29928130
J Exp Clin Cancer Res. 2018 Jul 13;37(1):148
pubmed: 30001742
Pharmacol Rev. 1993 Jun;45(2):177-203
pubmed: 8396782
Science. 1997 Jan 10;275(5297):218-20
pubmed: 8985016